ZTS Zoetis Inc: תחזית צמיחת רווח נקי למניה לשנה הבאה
Zoetis Inc. (ZTS) is implementing AI to automate veterinary diagnostics and drug production. The one-year forward EPS growth rate confirms this trajectory, with the value 0.00 recording the metric level. The company is scaling global sales of high-margin vaccines, offsetting R&D expenditures. Stable demand for pet care provides the issuer with a steady cash flow and operational efficiency.
Zoetis Corp (ZTS) - פילוחי מדדים ודוחות פיננסיים
This indicator reflects the daily price action of analyst consensus forecasts for earnings per share (EPS) growth rates for the coming year. For Zoetis Inc. (ZTS), this metric is sensitive to the commercial success of Librela and Solensia, as well as the demand for veterinary care. By analyzing this EPS forecast chart, investors assess market expectations for business scaling. Steady growth in this metric confirms the issuer's fundamental resilience.
